Table 1. Main characteristics and methodological quality of all eligible studies.
First author [Ref] | Year | Country | Ethnicity | Sample size | Gender (male/female) | Age (years) | Marker | Detection method | NOS score | |||
Case | Control | Case | Control | Case | Control | |||||||
Pimentel-Nunes P [13] | 2013 | Portugal | Caucasian | 193 | 278 | 123/70 | 176/102 | 62.0±7.0 | 56.0±4.0 | 299 A>G | PCR-RFLP | 7 |
Omrane I [10] | 2013 | Tunisia | African | 100 | 140 | 53/47 | 45/95 | 58.2±14.4 | 56.2±15.7 | 299 A>G | Direct sequencing | 8 |
399 C>T | Direct sequencing | 8 | ||||||||||
Dai Q [21] | 2012 | China | Asian | 268 | 268 | - | - | - | - | 299 A>G | PCR-RFLP | 6 |
Yang GG [22] | 2011 | China | Asian | 102 | 87 | 64/38 | 52/35 | 52 | 50 | 299 A>G | Direct sequencing | 6 |
399 C>T | Direct sequencing | 6 | ||||||||||
Boraska Jelavic T [17] | 2006 | Croatia | Caucasian | 89 | 88 | 61/28 | 61/67 | 61.5±9.5 | 61.5±9.5 | 299 A>G | PCR-RFLP | 6 |
399 C>T | PCR-RFLP | 6 | ||||||||||
Davoodi H [14] | 2011 | Malaysia | Asian | 60 | 50 | 30/30 | 25/25 | 30∼50 | 30∼50 | 299 A>G | PCR-RFLP | 6 |
399 C>T | PCR-RFLP | 6 | ||||||||||
Nihon-Yanagi Y [28] | 2012 | Japan | Asian | 50 | 50 | 22/28 | 68 (52∼90) | mRNA | RT-PCR | 7 | ||
Yu YH [30] | 2011 | China | Asian | 62 | 25 | - | - | mRNA | RT-PCR | 6 | ||
Huang HY [26] | 2010 | China | Asian | 63 | 63 | 35/28 | - | mRNA | RT-PCR | 7 | ||
Jin HM [27] | 2009 | China | Asian | 24 | 24 | 11/13 | 67 (35∼86) | mRNA | RT-PCR | 8 | ||
Tian F [29] | 2008 | China | Asian | 30 | 30 | 18/12 | 64 (51∼82) | mRNA | RT-PCR | 8 | ||
Hu KF [25] | 2013 | China | Asian | 40 | 20 | 27/13 | 32∼80 | Protein | SP | 8 | ||
Cheng ZL [23] | 2012 | China | Asian | 58 | 25 | 38/20 | 22∼83 | Protein | SP | 8 | ||
Guo YW [24] | 2007 | China | Asian | 70 | 70 | 42/28 | 33∼71 | Protein | Flow cytometry | 8 |
Legend: PCR-RFLP - polymerase chain reaction-restriction fragment length polymorphism; NOS - the Newcastle-Ottawa Scale.